Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2023 Filed Jun 7, 2023 20:10 UTC |
MARTIN JOSEPH RDirector
|
SaleCommon Stock | 2,400 | $43.07 | $103,368.00 |
DisclosureSEC source: 0001209191-23-035053 · doc4.xml · nonDerivative · entry 1 MARTIN JOSEPH R · CIK 0001195846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,175 F1 · balance_after: The total ownership reported has also been adjusted to correct an inadvertent overreporting of 5,382 shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:21 UTC |
Rosenblatt MichaelDirector
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009728 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,577 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:22 UTC |
Zane Ellen MDirector
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009729 · doc4.xml · nonDerivative · entry 1 Zane Ellen M · CIK 0001369850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,900 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC |
Nova Tina SusanDirector
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009725 · doc4.xml · nonDerivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,604 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:20 UTC |
PUHY DOROTHY EDirector
|
GrantCommon | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009727 · doc4.xml · nonDerivative · entry 1 PUHY DOROTHY E · CIK 0001200493 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,604 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:19 UTC |
Palepu Krishna G.Director
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009726 · doc4.xml · nonDerivative · entry 1 Palepu Krishna G. · CIK 0001345098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,393 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:15 UTC |
Davis Robyn CDirector
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009719 · doc4.xml · nonDerivative · entry 1 Davis Robyn C · CIK 0001580601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,122 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC |
McLaughlin EricaDirector
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009723 · doc4.xml · nonDerivative · entry 1 McLaughlin Erica · CIK 0001740348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC |
Casal FrankDirector
|
GrantCommon Stock | 3,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009714 · doc4.xml · nonDerivative · entry 1 Casal Frank · CIK 0001891819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 F1 · price: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:17 UTC |
MARTIN JOSEPH RDirector
|
GrantCommon Stock | 5,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009722 · doc4.xml · nonDerivative · entry 1 MARTIN JOSEPH R · CIK 0001195846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,957 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:10 UTC |
Zhou GingerSVP and General Manager, Genom
|
GrantCommon Stock | 323 | $46.92 | $15,155.16 |
DisclosureSEC source: 0001209191-23-006194 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,814 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:08 UTC |
Vacha RobinSVP, GM Life Science Products
|
GrantCommon Stock | 265 | $46.92 | $12,433.80 |
DisclosureSEC source: 0001209191-23-006189 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,499 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:08 UTC |
Sriram VandanaSVP Finance & Corp. Controller
|
GrantCommon Stock | 369 | $46.92 | $17,313.48 |
DisclosureSEC source: 0001209191-23-006186 · doc4.xml · nonDerivative · entry 1 Sriram Vandana · CIK 0001908223 · SVP Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,356 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:07 UTC |
Robertson Lindon GEVP & Chief Financial Officer
|
GrantCommon Stock | 279 | $46.92 | $13,090.68 |
DisclosureSEC source: 0001209191-23-006184 · doc4.xml · nonDerivative · entry 1 Robertson Lindon G · CIK 0001525267 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,458 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:06 UTC |
Crowley KimberlySVP, Chief HR Officer
|
GrantCommon Stock | 177 | $46.92 | $8,304.84 |
DisclosureSEC source: 0001209191-23-006181 · doc4.xml · nonDerivative · entry 1 Crowley Kimberly · CIK 0001878164 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,399 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:29 UTC |
Coyne MitchellSVP and GM, Life Sciences Proj
|
GrantCommon Stock | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058151 · doc4.xml · nonDerivative · entry 1 Coyne Mitchell · CIK 0001954137 · SVP and GM, Life Sciences Proj 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,889 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:27 UTC |
Zhou GingerSVP and General Manager, Genom
|
GrantCommon Stock | 1,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058149 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,491 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:26 UTC |
Vacha RobinSVP, GM Life Science Products
|
GrantCommon Stock | 3,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058147 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,234 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:25 UTC |
Sriram VandanaVP, Finance & Corp. Controller
|
GrantCommon Stock | 2,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058145 · doc4.xml · nonDerivative · entry 1 Sriram Vandana · CIK 0001908223 · VP, Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,987 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:23 UTC |
SCHWARTZ STEPHEN SDirector · CEO
|
GrantCommon Stock | 18,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058142 · doc4.xml · nonDerivative · entry 1 SCHWARTZ STEPHEN S · CIK 0001247436 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,527 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:21 UTC |
Robertson Lindon GEVP & Chief Financial Officer
|
GrantCommon Stock | 6,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058139 · doc4.xml · nonDerivative · entry 1 Robertson Lindon G · CIK 0001525267 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,179 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:20 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
GrantCommon Stock | 3,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058134 · doc4.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,780 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:18 UTC |
Gray David CChief Strategy & New Business
|
GrantCommon Stock | 3,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058126 · doc4.xml · nonDerivative · entry 1 Gray David C · CIK 0001454514 · Chief Strategy & New Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,219 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:16 UTC |
Crowley KimberlySVP, Chief HR Officer
|
GrantCommon Stock | 2,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058111 · doc4.xml · nonDerivative · entry 1 Crowley Kimberly · CIK 0001878164 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,222 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Long Term Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2023. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:21 UTC |
Zhou GingerSVP and General Manager, Genom
|
Tax withholdingCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057544 · doc4.xml · nonDerivative · entry 2 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,602 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 2,236 performance stock units and 544 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:21 UTC |
Zhou GingerSVP and General Manager, Genom
|
GrantCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057544 · doc4.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,282 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC |
Vacha RobinSVP, GM Life Science Products
|
Tax withholdingCommon Stock | 5,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057543 · doc4.xml · nonDerivative · entry 2 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,456 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 11,077 performance stock units and 2,505 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC |
Vacha RobinSVP, GM Life Science Products
|
GrantCommon Stock | 11,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057543 · doc4.xml · nonDerivative · entry 1 Vacha Robin · CIK 0001832620 · SVP, GM Life Science Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,294 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:18 UTC |
Sriram VandanaVP, Finance & Corp. Controller
|
Tax withholdingCommon Stock | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057542 · doc4.xml · nonDerivative · entry 1 Sriram Vandana · CIK 0001908223 · VP, Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,468 F1 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 273 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:17 UTC |
SCHWARTZ STEPHEN SDirector · CEO
|
Tax withholdingCommon Stock | 26,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057540 · doc4.xml · nonDerivative · entry 2 SCHWARTZ STEPHEN S · CIK 0001247436 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,641 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 48,580 performance stock units and 10,632 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:17 UTC |
SCHWARTZ STEPHEN SDirector · CEO
|
GrantCommon Stock | 48,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057540 · doc4.xml · nonDerivative · entry 1 SCHWARTZ STEPHEN S · CIK 0001247436 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,934 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:16 UTC |
Robertson Lindon GEVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 10,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057536 · doc4.xml · nonDerivative · entry 2 Robertson Lindon G · CIK 0001525267 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,883 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 20,403 performance stock units and 4,207 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:16 UTC |
Robertson Lindon GEVP & Chief Financial Officer
|
GrantCommon Stock | 20,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057536 · doc4.xml · nonDerivative · entry 1 Robertson Lindon G · CIK 0001525267 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,974 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:15 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
Tax withholdingCommon Stock | 4,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057532 · doc4.xml · nonDerivative · entry 2 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,002 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 10,687 performance stock units and 2,667 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:15 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
GrantCommon Stock | 10,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057532 · doc4.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,537 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:14 UTC |
Gray David CChief Strategy & New Business
|
Tax withholdingCommon Stock | 5,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057527 · doc4.xml · nonDerivative · entry 2 Gray David C · CIK 0001454514 · Chief Strategy & New Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,071 F2 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 10,200 performance stock units and 2,043 of restricted stock units held by the reporting person. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:14 UTC |
Gray David CChief Strategy & New Business
|
GrantCommon Stock | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057527 · doc4.xml · nonDerivative · entry 1 Gray David C · CIK 0001454514 · Chief Strategy & New Business 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,306 F1 · shares: Represents shares issued upon the vesting of performance-based units granted on November 11, 2019, which were subject to performance-based vesting requirements measured at the three-year period ended September 30, 2022. No amount was paid by the reporting person upon grant or vesting of the performance-based units. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:12 UTC |
Crowley KimberlySVP, Chief HR Officer
|
Tax withholdingCommon Stock | 574 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057523 · doc4.xml · nonDerivative · entry 1 Crowley Kimberly · CIK 0001878164 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,703 F1 · shares: The forfeiture of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2022 of 1,936 of restricted stock units held by the reporting person. Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 20:10 UTC |
Robertson Lindon GEVP & Chief Financial Officer
|
PurchaseCommon Stock | 4,350 | $57.62 | $250,647.00 |
DisclosureSEC source: 0001209191-22-047013 · doc4.xml · nonDerivative · entry 1 Robertson Lindon G · CIK 0001525267 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,571 F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $57.53 to $57.64. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 20:10 UTC |
McManus MatthewEVP & Chief Operating Officer
|
PurchaseCOMMON | 8,625 | $58.15 | $501,543.75 |
DisclosureSEC source: 0001209191-22-047012 · doc4.xml · nonDerivative · entry 1 McManus Matthew · CIK 0001908268 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,467 F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $57.99 to $58.32. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:16 UTC |
Crowley KimberlySVP, Chief HR Officer
|
GrantCommon Stock | 144 | $57.49 | $8,278.56 |
DisclosureSEC source: 0001209191-22-043655 · doc4.xml · nonDerivative · entry 1 Crowley Kimberly · CIK 0001878164 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,277 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:15 UTC |
De Jesus LindaChief Commercial Officer, LS
|
GrantCommon | 43 | $57.49 | $2,472.07 |
DisclosureSEC source: 0001209191-22-043657 · doc4.xml · nonDerivative · entry 1 De Jesus Linda · CIK 0001878072 · Chief Commercial Officer, LS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,764 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:15 UTC |
Robertson Lindon GEVP & Chief Financial Officer
|
GrantCommon Stock | 98 | $57.49 | $5,634.02 |
DisclosureSEC source: 0001209191-22-043656 · doc4.xml · nonDerivative · entry 1 Robertson Lindon G · CIK 0001525267 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,221 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act. Read SEC document |
| July 29, 2022 Filed Aug 1, 2022 20:15 UTC |
Sriram VandanaVP, Finance & Corp. Controller
|
GrantCommon Stock | 292 | $57.49 | $16,787.08 |
DisclosureSEC source: 0001209191-22-043654 · doc4.xml · nonDerivative · entry 1 Sriram Vandana · CIK 0001908223 · VP, Finance & Corp. Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,549 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| April 12, 2022 Filed Jun 7, 2022 22:59 UTC |
Crowley KimberlySVP, Chief HR Officer
|
SaleCommon Stock | 132 | $78.02 | $10,298.64 |
DisclosureSEC source: 0001209191-22-034904 · doc4.xml · nonDerivative · entry 1 Crowley Kimberly · CIK 0001878164 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,133 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on April 12, 2022 of 306 restricted stock units held by the reporting person and previously reported on Form 3. Read SEC document |
| February 11, 2022 Filed Jun 9, 2022 21:12 UTC |
Zane Ellen MDirector
|
GrantCommon Stock | 1,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035464 · doc4.xml · nonDerivative · entry 1 Zane Ellen M · CIK 0001369850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,296 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 11, 2022 Filed Jun 9, 2022 21:10 UTC |
WRIGHTON MARK SDirector
|
GrantCommon Stock | 1,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035458 · doc4.xml · nonDerivative · entry 1 WRIGHTON MARK S · CIK 0001021584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,818 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 11, 2022 Filed Jun 9, 2022 21:09 UTC |
WOOLLACOTT ALFRED IIIDirector
|
GrantRestricted Stock · Derivative | 1,922 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035454 · doc4.xml · derivative · entry 2 WOOLLACOTT ALFRED III · CIK 0001225004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,554 Underlying: Common Stock · 1,922 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F3 · price: Grant of RSUs under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. Read SEC document |
| February 11, 2022 Filed Jun 9, 2022 21:07 UTC |
Rosenblatt MichaelDirector
|
GrantCommon Stock | 1,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035452 · doc4.xml · nonDerivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,973 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 11, 2022 Filed Jun 9, 2022 21:06 UTC |
Palepu Krishna G.Director
|
GrantCommon Stock | 1,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035450 · doc4.xml · nonDerivative · entry 1 Palepu Krishna G. · CIK 0001345098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,789 F1 · price: Grant of unrestricted shares under the company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.